Cover Image

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes

Ali Kadivar,1 Behnam Kamalidehghan,1 Hamid Akbari Javar,2 Benyamin Karimi,3 Reihaneh Sedghi,4 Mohamed Ibrahim Noordin1 1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 2Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kadivar A (Author), Kamalidehghan B (Author), Akbari Javar H (Author), Karimi B (Author), Sedghi R (Author), MI Noordin (Author)
Format:	Book
Published:	Dove Medical Press, 2017-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Imatinib inhibits pericyte-fibroblast transition and inflammation and promotes axon regeneration by blocking the PDGF-BB/PDGFRβ pathway in spinal cord injury
by: Fei Yao, et al.
Published: (2022)

Effects of ginsenoside Rb1 on second-degree burn wound healing and FGF-2/PDGF-BB/PDGFR-β pathway modulation
by: Li Zhang, et al.
Published: (2021)

Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy
by: Anca Maria Cimpean, et al.
Published: (2010)

Endothelial Cells Promote Migration of Mesenchymal Stem Cells via PDGF-BB/PDGFRβ-Src-Akt in the Context of Inflammatory Microenvironment upon Bone Defect
by: Sihao He, et al.
Published: (2022)

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
by: Omar S Din, et al.
Published: (2008)

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
by: Bożena Karolewicz, et al.
Published: (2019)

PDGFR-β mediated growth failure in pediatric CML cases on Imatinib
by: Prakamya Gupta, et al.
Published: (2020)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
by: Madsen Christine, et al.
Published: (2012)

Generalized lichenoid drug eruption associated with imatinib mesylate therapy
by: Sudip Kumar Ghosh
Published: (2013)

Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
by: Alexandra Rodrigues Alves, et al.

Genes Involved in the Transcriptional Regulation of Pluripotency Are Expressed in Malignant Tumors of the Uterine Cervix and Can Induce Tumorigenic Capacity in a Nontumorigenic Cell Line
by: Graciela Ruiz, et al.
Published: (2019)

Endotoxin Triggers Tumor Initiation Events in Nontumorigenic Breast Epithelial Cells and Enhances Invasion-Related Phenotype in Pretumorigenic and Tumorigenic Breast Epithelial Cells
by: Farah Yassine, et al.
Published: (2021)

Total Flavonoids of Rhizoma Drynariae Enhances Angiogenic-Osteogenic Coupling During Distraction Osteogenesis by Promoting Type H Vessel Formation Through PDGF-BB/PDGFR-β Instead of HIF-1α/ VEGF Axis
by: Zhen Shen, et al.
Published: (2020)

Imatinib mesylate-induced cutaneous rash masquerading as pityriasis rosea of Gilbert
by: Prashant Verma, et al.
Published: (2014)

Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44+/CD24-/low): an in vitro study
by: Ahmadipour F, et al.
Published: (2015)

Effect of Endurance Training and Stem Cell Injection on PDGF and PDGFr Gene Expression in Knee Tissue of Rats with Knee Osteoarthritis
by: khadige niknam, et al.
Published: (2020)

Histological changes of the rat liver after administration of imatinib mesylate:an experimental study
by: Luma Ibrahim Khalel Al-Allaf, et al.
Published: (2019)

Inhibitory Effects of Docetaxel on Platelet-Derived Growth Factor (PDGF)-BB-Induced Proliferation of Vascular Smooth Muscle Cells Through Blocking PDGF-Receptor β Phosphorylation
by: Eun Seok Park, et al.
Published: (2011)

Multiple eruptive dermatofibromas secondary to imatinib mesylate in a patient with chronic myeloid leukemia
by: Francisco J Lira-Valero, et al.
Published: (2021)

Recurrent dermatofibrosarcoma protuberans treated with neoadjuvant imatinib mesylate followed by Mohs micrographic surgery
by: Natalia M. Fontecilla, BA, et al.
Published: (2017)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013)

Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells
by: Fani S, et al.
Published: (2015)

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells
by: Mohammed H. Abdelaziz, et al.
Published: (2023)

Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects
by: Joo Young Na, et al.
Published: (2022)

Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines
by: Kulkarni Hemant, et al.
Published: (2012)

Effects of Non-Collagenous Proteins, TGF-β1, and PDGF-BB on Viability and Proliferation of Dental Pulp Stem Cells
by: Fahimeh Sadat Tabatabaei, et al.
Published: (2016)

Decreased plasma levels of PDGF-BB, VEGF-A, and HIF-2α in preterm infants after ibuprofen treatment
by: Xuemei Huang, et al.
Published: (2022)

Evaluation of the Anticancer Activity of Calcium Ions Introduced into Human Breast Adenocarcinoma Cells MCF-7/WT and MCF-7/DOX by Electroporation
by: Katarzyna Bieżuńska-Kusiak, et al.
Published: (2023)

MCF-7 and its Multidrug Resistant Variant MCF-7/ADR Overcome TNF Cytotoxicity through Prevention of Reactive Oxygen Species Accumulation
by: Morteza Ghandadi, et al.
Published: (2019)

Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media
by: Ozlem Coban, et al.
Published: (2020)

Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells
by: Adam Hermawan, et al.
Published: (2010)

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways
by: Ren H, et al.
Published: (2019)

Ulinastatin Inhibits the Proliferation, Invasion and Phenotypic Switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP Signaling Pathway
by: Huang C, et al.
Published: (2020)

Factors Influencing the Steady-State Plasma Concentration of Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors and Chronic Myeloid Leukemia
by: Yan Chen, et al.
Published: (2020)

The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells
by: Evren Atlihan Gundogdu, et al.
Published: (2020)

Study of correlation between imatinib mesylate plasma levels and hematological profile of patients undergoing treatment for chronic myeloid leukemia
by: Emanuelle S. Dal Ponte, et al.
Published: (2017)

Successful Long-Term Control of the Syndrome of Episodic Angioedema With Eosinophilia (Gleich Syndrome) With Low-Dose Imatinib Mesylate and Prednisone
by: Joseph H. Butterfield MD
Published: (2021)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
by: Xu Wang, et al.
Published: (2019)

Effect of Allicin on Tamoxifen-sensitive MCF-7 Breast Cancer Cells
by: P Rahimi-Moghaddam, et al.
Published: (2015)

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells
by: Javid Shahbazi, et al.
Published: (2013)